Overview
Richard Pazdur is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Pazdur is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Breast Cancer, Tissue Biopsy, and Nephrectomy.
His clinical research consists of co-authoring 374 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Plasmacytoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Maryland Community Medical Group Inc
Harvinder Singh is a Hematologist Oncology specialist and an Oncologist in Glen Burnie, Maryland. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Familial Colorectal Cancer, Pleuropulmonary Blastoma, Lung Cancer, Plasmacytoma, and Bone Marrow Aspiration. Dr. Singh is currently accepting new patients.
Medstar Medical Group Ii LLC
Aarthi Shenoy is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Shenoy is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration.
The Center For Cancer & Blood Disorders
Dr. Ralph V. Boccia is a hematologist affiliated with Sibley Memorial Hospital, Suburban Hospital, Shady Grove Adventist Hospital, Holy Cross Hospital and MedStar Georgetown University Hospital, where he is a clinical associate professor of medicine for the University, as well as the medical director of the International Oncology Network (ION) Clinical Research Program and the chairman of ION’s Medical Advisory Panel. He practices out of the Center for Cancer and Blood Disorders, of which he is the founder and medical director, located in Bethesda, Maryland and Germantown, Maryland. Dr. Boccia earned his medical degree from the Autonomous University of Guadalajara School of Medicine. He completed a residency in internal medicine at Kern Medical Center, followed by a fellowship in hematology, oncology and bone marrow transplant at the combined UCLA-Veterans Administration Program and The National Cancer Institute at the National Institutes of Health. Dr. Boccia is a member of the American College of Physicians, the American Society of Clinical Oncology, the American Society of Hematology and the American Society for Blood and Marrow Transplantation. Dr. Boccia has been listed as a Top Doctor by Washingtonian Magazine and Consumers’ Checkbook Magazine since 1992. He has also been recognized as a Super Doctor by The Washington Post Magazine and a Regional Top Doctor for Washington, D.C., Baltimore and Washington-Baltimore by Castle Connolly. Dr. Boccia has contributed to various articles with his research, published in journals such as Annals of Internal Medicine, Journal of Clinical Oncology and The Lancet. Recent News Articles and Media Coverage Bladder cancer trends in Montgomery and Prince George's counties: Welcome news - and 3 facts you need to know. NJ.com (08/16/2016) RCCA Expands to Maryland to Become One of the Nation's First Multi-State Oncology/Hematology Physician-Owned and -Operated Networks. OncLive (10/06/2015). Dr. Boccia is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Anemia, Multiple Myeloma, Thrombocytopenia, Adult Immune Thrombocytopenia, and Splenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Pazdur isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Pazdur isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Acute Myeloid Leukemia (AML)Dr. Pazdur isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Breast CancerDr. Pazdur isAdvanced. Learn about Breast Cancer.
- LeukemiaDr. Pazdur isAdvanced. Learn about Leukemia.
- Multiple MyelomaDr. Pazdur isAdvanced. Learn about Multiple Myeloma.
- Renal Cell Carcinoma (RCC)Dr. Pazdur isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Pazdur isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Soft Tissue SarcomaDr. Pazdur isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Pazdur isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Pazdur isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- B-Cell LymphomaDr. Pazdur isExperienced. Learn about B-Cell Lymphoma.
- Bladder CancerDr. Pazdur isExperienced. Learn about Bladder Cancer.